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Abstract
Increases in 25-hydroxyvitamin D concentrations are shown to improve muscle strength in adults; 
however, data in pediatric populations are scant and equivocal. In this ancillary study of a larger-
scale, multi-sited, double-blind, randomized, placebo-controlled vitamin D intervention in US 
children and adolescents, we examined the associations between changes in vitamin D metabolites 
and changes in muscle mass, strength, and composition following 12-weeks of vitamin D3 
supplementation. Healthy male and female, black and white children and adolescents between the 
ages of 9-13 years old from two US states (Georgia 34°N and Indiana 40°N) were enrolled in the 
study and randomly assigned to receive an oral vitamin D3 dose of 0, 400, 1,000, 2,000 or 4,000 
IU/d for 12 weeks between the winter months of 2009 to 2011 (N=324). Analyses of covariance, 
partial correlations, and regression analyses of baseline and 12-week changes (post-baseline) in 
vitamin D metabolites (serum 25(OH)D, 1,25(OH)2D, intact parathyroid hormone (iPTH)) and 
outcomes of muscle mass, strength, and composition (total body fat-free soft tissue (FFST), 
handgrip strength, forearm and calf muscle cross-sectional area (MCSA), muscle density, and 
intermuscular adipose tissue (IMAT)) were assessed. Serum 25(OH)D and 1,25(OH)2D, but not 
iPTH, increased over time, as did fat mass, FFST, forearm and calf MCSA, forearm IMAT, and 
handgrip strength (p<0.05). Vitamin D metabolites were not associated with muscle strength at 
baseline nor following the 12-week intervention. Changes in serum 25(OH)D correlated with 
decreases in forearm IMAT, while changes in serum iPTH predicted increases in forearm and calf 
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MCSA and IMAT (p<0.05). Overall, increases in 25(OH)D did not influence muscle mass or 
strength in vitamin D sufficient children and adolescents; however, the role of iPTH on muscle 
composition in this population is unknown and warrants further investigation.
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Introduction
Vitamin D insufficiency (< 50 nmol/L) is highly prevalent amongst older adults(1) and is 
becoming more commonly documented in children(2). Classically, vitamin D plays an 
essential role in calcium regulation and bone metabolism, and vitamin D insufficiency is 
associated with low bone mass and an increased risk of skeletal fracture(3). However, over 
the past few decades there has been increased interest in the non-skeletal effects of vitamin 
D. Muscle has been of particular interest as vitamin D deficiency (< 20 nmol/L) is associated 
with proximal limb myopathy(4) and vitamin D insufficiency with impaired muscle 
function(5).
Older adults with low circulating 25-hydroxyvitamin D (25(OH)D), indicative of vitamin D 
insufficiency, have decreased muscle strength and poor muscle function illustrated by 
decreased thigh muscle strength(6) and power(7), weak handgrip strength(8), reduced gait 
speed(6), and a prolonged sit-to-stand time(9). In adolescents, lower circulating 25(OH)D has 
likewise been associated with decreased muscle strength and poor muscle function(10-12). 
Though vitamin D supplementation is shown to improve muscle-related outcomes in 
adults(13), only two randomized clinically controlled trials have examined this relationships 
in adolescents(14,15). In the first study, vitamin D insufficient (35 nmol/L) Lebanese 
adolescent females (N=168, aged 10-17 years) were supplemented with weekly oral vitamin 
D3 doses of 1,400 IU, 14,000 IU or placebo for one year. Following the intervention, 
significant increases in total body lean muscle mass were observed in pre-menarcheal, but 
not post-menarcheal females(14). In the second study, a group of predominately vitamin D 
deficient (18 nmol/L) South Asian adolescent females (N=69, aged 12-14 years) received an 
oral vitamin D2 dose of 150,000 IU or placebo every three months for one year. Following 
the intervention, an improvement in movement efficiency, indicating an improvement in 
flexibility and neuromuscular coordination, was observed(15).
The two previously described trials were limited to adolescent females with insufficient or 
deficient baseline 25(OH)D concentrations and were predominately in those of Middle 
Eastern or South Asian ancestry. Whether increasing serum 25(OH)D concentrations 
improves muscle-related outcomes in vitamin D sufficient (>50 nmol/l) children and 
adolescents, of both sexes, is unknown. Additionally, no studies to date have examined the 
relationship between 25(OH)D and muscle mass, strength, or composition in black children 
or adolescents, which is particularly relevant given their high prevalence of low serum 
circulating 25(OH)D concentrations(16). Therefore, the purpose of this ancillary analysis of a 
12-week randomized, placebo-controlled vitamin D intervention was to determine if changes 
Wright et al. Page 2
J Bone Miner Res. Author manuscript; available in PMC 2019 June 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
in vitamin D metabolites were associated with changes in muscle-related outcomes 
including size, strength, and composition in black and white, male and female children and 
adolescents. We hypothesized that increases in circulating 25(OH)D concentrations would 
improve muscle-related outcomes following the 12-week intervention.
Materials and Methods
Study Participants and Design
Data from The University of Georgia, Purdue University, and Indiana University (GAPI) 12-
week vitamin D intervention in US children ages 9 to 13 years (N=324) from two different 
latitudes (34°N or 40°N) were used for this ancillary study(17). Briefly, participants were 
healthy white (n=159) and black (n=165), males (n=162) and females (n=162) from 
southern (n=161) or northern (n=163) locations who following enrollment during the winter 
months (October through December) of 2009 to 2010 and 2010 to 2011, when serum 
25(OH)D is at its nadir, were randomly assigned to receive an oral vitamin D3 dose of 0, 
400, 1,000, 2,000 or 4,000 IU/d for 12 weeks. Pubertal status was kept consistent between 
participants by recruiting those with sexual maturity ratings of 2 and 3, estimated using a 
validated self-assessment questionnaire for genitalia or breast development in a mixed ethnic 
population(18-20) Participants taking nutritional supplements were enrolled after a 4-week 
washout period, and all participants agreed to not alter their dietary or physical activity 
patterns throughout the 12-week intervention. Additional details regarding the study 
participants, recruitment, blinding, randomization scheme and allocation, and participant 
flow were previously reported in Lewis et al.(17)
Exclusion criteria included achievement of menarche (for females), pre-existing muscle or 
bone disorders, growth disorders, or medications/supplements known to influence vitamin D 
metabolism. Serum 25(OH)D, 1,25-dihydroxyvitamin D [1,25(OH)2D], intact parathyroid 
hormone (iPTH), indices of total body composition (fat-free soft tissue mass (FFST), fat 
mass, body fat percent), forearm and calf muscle cross-sectional area (MCSA), muscle 
density (MD), intermuscular adipose tissue (IMAT), and handgrip strength were assessed at 
baseline and following the 12-week intervention. Dietary intake and physical activity data 
were also collected for use as possible covariates in the analyses. Each university’s 
Institutional Review Board on Human Subjects Research approved the current study.
Statistical power calculations were not conducted for this ancillary analysis. Original power 
calculations are published elsewhere and were based upon fractional calcium absorption, 
25(OH)D, 1,25(OH)2D, and iPTH, with 25(OH)D acting as the primary sample size 
determinant (17). However, the allotted sample size provided the parent study more than 90% 
power (α= 0.05) to detect differences in 25(OH)D concentrations among the five-
supplementation groups with forty-eight participants per group. Retrospectively, a 7.4% 
difference in total lean mass change following a +27.5 nmol/L (placebo) versus +69.9 
nmol/L (2,000 IU/d) increase in 25(OH)D concentrations in 15 participants could be 
detected with 90% power (2-sided significance), according to a previous vitamin D 
supplementation trial in school children(14).
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Biochemical Analyses
Blood samples were collected following an overnight fast and left to sit for 30-60 minutes to 
coagulate before centrifuging at 4°C and 1,800 RPMs for 15 minutes. All samples were then 
prepared for storage and frozen at < −70°C until further analyses. Reference controls (kits) 
and internal controls (in-house pooled samples) were included with each assay run for 
quality control. All assays were conducted in duplicate using a block design, such that 
baseline and 12-week samples from the same subject were assayed at the same time using 
the same kit by the same investigator who was blinded to participant race, sex, and 
treatment. Repeat analyses were conducted if duplicate samples differed by >10%. Serum 
25(OH)D was assessed using a 2-step radioimmunoassay (DIASORIN, 25 hydroxyvitamin 
D hydroxyvitamin D 125I RIA kit, no.68100, Stillwater, MN, 100 tube kit). The inter- and 
intra-assay coefficients of variation (CV) were 5.2 – 8.7% and 5.5 – 8.2%, respectively, and 
analytical reliability was further monitored through laboratory participation in DEQAS 
(Vitamin D External Quality Assessment Scheme). Serum 1,25(OH)2D was assessed using a 
2-step radioimmunoassay (DIASORIN, 1,25-dihydroxyvitamin D 125I RIA kit, no. 65100E, 
Stillwater, MN, 100 tube kit). The inter- and intra-assay CV were 12.4% to 17.6% and 
11.6%, respectively. Serum iPTH was assessed using an immunoradiometric assay 
(DIASORIN, N-tact iPTH SP kit, no. 26100, Stillwater, MN 100 beads/kit). The inter- and 
intra-assay CV were 0.5 to 3.0% and 3.1 to 9.4%, respectively.
Whole Body Composition
Dual energy X-ray absorptiometry (DXA)—Total body FFST (kg), fat mass (kg) and 
percent body fat (%) were measured using DXA (Delphi A Hologic Inc. [University of 
Georgia site]; GE Healthcare Lunar iDXA, GE Medical Instruments [Purdue University 
site]; Hologic Discovery-W [Indiana University site]) at baseline and 12 weeks. For 
consistency, the same technician at each study site performed all analyses. DXA quality 
control for soft tissue was assured by standard protocols. Intra-class correlation coefficients 
(ICCs) were calculated in young females 5 to 8 years of age (n=10) scanned twice at the 
University of Georgia site during a 7-day period for measures of body composition (ICC≥ 
0.98). Short- and long-term DXA precision at the Purdue and Indiana University’s sites 
demonstrates errors of less than 2%. Instruments from all three sites were cross-calibrated 
and study-specific conversion equations were developed to standardize the baseline and 12-
week change data for whole body composition outcomes for all statistical analyses(21).
Muscle Composition
Peripheral quantitative computed tomography (pQCT)—Non-dominant calf and 
forearm MCSA (mm2), MD (g/cm2) and intermuscular adipose tissue (IMAT, mm2) were 
measured at 66% of the bone length from the distal radius and tibia by pQCT (XCT-2000; 
Stratec Medizintechnic, Pforzheim, Germany) at baseline and 12 weeks. MCSA, MD, and 
IMAT were each assessed through multiple analyses of the same tomographic slice. MCSA 
of the forearm and calf are shown to be surrogate markers of muscle strength(22). To 
measure MCSA, both subcutaneous fat and bone area were individually quantified and 
subtracted from the total volume of interest. Subcutaneous fat was quantified by contour 
mode 1 and peel mode 1 using a threshold of 34 mg/cm3, while bone area was quantified 
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using a threshold of 710 mg/cm3. To assess MD, muscle bone area (MBA) and density 
(MBD) were first quantified and separated from adipose tissue using a threshold of 40 
mg/cm3. Additional indices of bone area (BA) and bone density (BD) were further 
quantified using a threshold of 150 mg/cm3 and MD was calculated from the following 
equation: Muscle Density = ((MBD + (MBA / BA)) − BD)/((MBA − BA) / BA). To assess 
IMAT, defined in this manuscript as adipose tissue located beneath the fascia and in-between 
or inside muscle fibers, a contour mode 3 and peel mode 2 non-filtered analysis using a 
threshold of −101 mg/cm3 and an inner threshold of 40 mg/cm3 was used to separate total 
fat from muscle and bone. Subcutaneous fat (threshold −101 mg/cm3, inner threshold 40 
mg/cm3) and bone marrow (threshold 710 mg/cm3, inner threshold −101 mg/cm3) were then 
subtracted from total fat to produce an IMAT value.
Scans with excessive motion (radius, n = 34; tibia, n = 16) were not included in any muscle 
analyses. Comparability of muscle data from each study site/scanner was achieved through a 
minimum of 20 phantom scans per scanner. Quality assurance was verified with daily 
phantom scans. Test-retest measurements were performed on five females, aged 18 to 24 
years, to determine reliability of the pQCT at the University of Georgia site. ICCs for all 
pQCT measurements were calculated as ICC ≥ 0.97(23). Similar reliability measures were 
shown at Indiana sites, with a root mean square CV of <1% for bone density, mass, and 
structure, and <1.5% for MCSA in 30 healthy individuals scanned six times with interim 
repositioning(24).
Handgrip strength—Maximum isometric strength of the non-dominant hand was 
assessed using a handgrip dynamometer (Jamar Plus+ Digital Hand Dynamometer; 
Patterson Medical, Bolingbrook, IL) by the same technician at each site at baseline and 12 
weeks. Handgrip strength is a valid measurement of total body muscle strength(25) and 
physical fitness (speed, agility, flexibility, jumping)(26) in pediatric populations. At baseline, 
the technician adjusted the handle of the dynamometer for the most comfortable gripping 
position for each subject (1st and 2nd position for children), noted the subject specific setting, 
and repeated the same setting at 12 weeks. Three measurements were taken 30 seconds apart 
and the average of the three tests was recorded. Test- retest measurements in 11 participants 
(4 white males, 3 white females, 3 black males, and 1 black female) aged 9 to 13 years were 
conducted in a single day (3 hours apart) with a 30-second rest period between triplicate 
measurements and showed an average ICC for handgrip strength of ICC=0.98. The 
correlation coefficient of the handgrip dynamometer in assessing grip strength of the 
dominant and non-dominant hand in children has been reported as 0.97 (95% confidence 
interval: 0.95 to 0.98) and 0.95 (95% confidence interval: 0.92 to 0.96), respectively(27).
Dietary Intake & Physical Activity
Three-day food records (2 weekdays and 1 weekend day) were completed by participants 
and their parents at both baseline and 12 weeks to assess intakes of energy (kcal), vitamin D 
(IU) and calcium (mg). Three-day food records have been shown in adolescents as reliable 
tools for estimating energy and nutrient intakes(28). Diet records were analyzed using Food 
Processor SQL version 9.7.3 (ESHA Research). The three-day physical activity recalls 
(3DPAR, 1 weekend day and 2 weekdays)(29) were administered by a trained interviewer 
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and used to quantify each participant’s type, duration and intensity of physical activity at 
baseline and 12 weeks. A metabolic equivalent (MET) value was assigned to each 30-minute 
time block based upon activity type, duration and level of intensity.
Statistics
The objective of this ancillary study was to determine the relationship between vitamin D 
metabolites (serum 25(OH)D, 1,25(OH)2D, iPTH) and muscle-related outcomes (muscle 
mass, strength, and composition) both at baseline and their changes over the 12-week 
intervention. Therefore, the effect of vitamin D3 dose on both independent and dependent 
variables were not examined. This effect of vitamin D3 dose on vitamin D metabolites and 
the overall compliance to supplementation have previously been published(17). Baseline 
group differences between race and sex were examined using two-way ANOVA. Changes 
over the 12-week intervention were determined by paired t-test, and a two-way ANOVA was 
used to determined differences in change values due to race and sex. Serum and muscle-
related outcomes were expressed as continuous variables and were tested for normality by 
the Shapiro-Wilk and the Dixon tests to reveal a non-normal distribution for all serum and 
muscle-related outcomes. Therefore, a two-step power transformation was applied to satisfy 
the assumption of normally distributed errors(30). The presence of outliers were also noted 
for multiple muscle-related outcomes and removed according to the extreme studentized 
deviate test(31). Physical activity and dietary intake did not change over the 12-week 
intervention and were not associated to vitamin D metabolites or muscle-related outcomes at 
baseline or 12-weeks. Therefore, physical activity and diet were not included as covariates in 
future analyses. Partial correlation analyses, adjusted for race, sex, age, and latitude, were 
performed to assess relationships between baseline and 12-week changes (i.e., post-pre) in 
vitamin D metabolites (25(OH)D, 1,25(OH)2D, iPTH), and baseline and 12-week changes 
(i.e., post-pre) in muscle-related outcomes (muscle mass, strength, and composition). 
Multiple linear regression analyses, adjusted for race, sex, age, and latitude, were further 
performed to assess the effect of changes in vitamin D metabolites on changes in muscle-
related outcomes. Statistical analyses were performed using the SPSS statistical package 
(IBM SPSS Statistics for Windows, Version 22.0 [IBM Corp: Armonk, NY]), and statistical 
significance was denoted upon ap-value ≤ 0.05.
Results
Baseline Characteristics (Table 1)
Black vs. white subjects were generally heavier, younger, and less physically active, with 
greater forearm and calf IMAT concentrations and lower muscle density, stronger grip 
strength, lower calcium intake, lower serum 25(OH)D, but higher serum iPTH and 
1,25(OH)2D concentrations. Males vs. females were older, taller, lighter for their age, 
displayed greater lean mass, less fat mass, larger forearms with higher IMAT concentrations, 
higher daily energy intakes, and lower serum 1,25(OH)2D concentrations. Mean 25(OH)D 
for the overall sample at baseline was ~70 nmol/L. Subjects with serum 25(OH)D 
concentrations below 50 nmol/L and 30 nmol/L were 13% and 2%, respectively.
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Baseline Partial Correlations
Partial correlations between baseline vitamin D metabolites and muscle-related outcomes, 
adjusted for covariates (age, race, sex, and latitude), are presented in Table 2. Baseline serum 
iPTH was positively correlated with FFST (r=0.145,/p=0.030) and forearm MCSA (r=0.152, 
p=0.022).
12-week Changes Following Intervention (Table 3)
304 participants completed the 12-week intervention, yielding a 94% retention rate and is 
described in detail by Lewis et al.(17). Weight, BMI-For-Age, fat mass, FFST, handgrip 
strength, forearm MCSA (p ≤ 0.001) and IMAT (p = 0.001), as well as calf MCSA (p = 
0.025) increased over the 12-week intervention. Mean serum 25(OH)D and 1,25(OH)2D, but 
not iPTH, increased from baseline to 12 weeks (p<0.0001). Changes in serum and muscle-
related outcomes did not differ between males and females nor whites and blacks over the 
12-week intervention.
12-week Change Partial Correlations
Partial correlations for 12-week absolute changes in vitamin D metabolites and muscle-
related outcomes (i.e., post-pre) are shown in Table 4. Age and race were positively 
correlated with changes in FFST (Age: r=0.166,p=0.005; Race: r=−0.156,p=0.008) and arm 
MCSA (Age: r=0.14,p=0.019; Race: r=−0.128,p=0.031). Changes in serum 25(OH)D were 
negatively correlated with changes in forearm IMAT (r= −0.173, p=0.029). Changes in 
serum iPTH, unadjusted or adjusted, were positively correlated with changes in forearm and 
calf MCSA, and forearm and calf IMAT. Neither baseline nor changes in dietary intakes of 
calcium and vitamin D or physical activity were associated with changes in serum vitamin D 
metabolites or muscle-related outcomes.
Multiple Linear Regression: Effects of vitamin D metabolites on muscle-related outcomes
Results from multiple linear regression analyses between 12-week changes in vitamin D 
metabolites (independent variable) and 12-week changes in muscle-related outcomes 
(dependent variable), adjusted for covariates (age, race, sex, and latitude), are presented in 
Table 5. Increases in serum iPTH predicted increases in calf MSCA (β=0.180,p=0.003), as 
well as forearm (β=0.135,p>=0.035) and calf IMAT (β=0.135,p=0.038). A trend was also 
present for serum iPTH and FFST (β=0.112,pτ=0.054).
Discussion
Changes in muscle mass and strength were not related to changes in 25(OH)D, despite large 
increases in serum 25(OH)D concentrations up to 155.7 nmol/L following the 12-week 
vitamin D3 intervention. These results contradict previous vitamin D interventions in adults, 
where increases in serum 25(OH)D were associated with increases in muscle fiber size(32) 
and improvements in muscle strength(33) and power(34). In-vitro studies further support this 
notion showing alterations in calcium signaling pathways and myocellular gene expression 
following 25(OH)D or 1,25(OH)2D exposure(35-37). However, in agreement with the current 
study, improvements in serum 25(OH)D have also shown a neutral effect on muscle-related 
outcomes including a lack of an effect on muscle strength(38,39), muscle function, or the risk 
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of falling(40,41). Though alleviating vitamin D deficiency (<20 nmol/L) through 
supplementation improves muscle-related outcomes(32-34,38,42,43), whether such effects 
occur in the absence of deficiency in both adolescents and adults (>20 nmol/L) is still 
unclear.
The current study is one of only three randomized clinically-controlled trials that examined 
the influence of changes in vitamin D metabolites on muscle-related outcomes in 
adolescents(14,15). The study by El-Hajj Fuleihan et al.(14) showed that increases in 25(OH)D 
increased total body FFST in Lebanese females, while the study by Ward et al.(15) showed 
improvements in movement efficiency in a predominately South Asian female population. In 
contrast, the current study showed no such improvements in muscle mass or strength which 
may be explained by the length of the vitamin D intervention (i.e., 12-weeks vs. 12-months) 
and baseline vitamin D status of each study population (i.e., sufficient vs. insufficient).
Though shorter in duration in comparison to the two previous 12-month interventions(14,15), 
the current study demonstrated increases in 25(OH)D, 1,25(OH)2D, FFST, handgrip 
strength, and forearm and calf MCSA following the 12-week vitamin D intervention. These 
results are reasonable given the rapid rate of growth associated with the early stages of 
puberty(44). However, baseline 25(OH)D concentrations in the two previous 
interventions(14,15) were considerably lower in comparison to the current study (i.e., average 
35 nmol/L and 18 nmol/L vs. ~70 nmol/L, respectively). The lack of association between 
increasing serum 25(OH)D concentrations and changes in muscle mass and strength in the 
current study suggest that changes in muscle-related outcomes are only apparent when 
baseline 25(OH)D concentrations are insufficient(14) or deficient(15).
Akin to cross-sectional studies in adults(45-47), increases in serum 25(OH)D were correlated 
with decreases in forearm IMAT over the 12-week vitamin D intervention following 
adjustment for race, sex, age, and latitude. The etiology of IMAT accumulation is still 
unknown, but is believed to be the result of impairments in mitochondrial function and 
muscle lipid metabolism(48). Vitamin D supplementation has shown to improve 
mitochondrial function(49) and regulate genes involved in lipogenesis and fatty acid 
metabolism(50), which could explain the current study results. Yet, associations between 
serum 25(OH)D and forearm or calf IMAT concentrations were not present following 
regression analyses. Therefore, though improvements in muscle composition following 
increases in 25(OH)D are present and plausible, further investigation is needed to confirm 
the current study result.
This study is among the first to report a positive relationship between iPTH and muscle-
related outcomes in a pediatric population. Twelve-week changes in iPTH, after adjusting 
for covariates, were positively correlated with and even predicted changes in forearm and 
calf MCSA and IMAT; suggesting an overall bigger and fatter muscle with higher serum 
iPTH. In conjunction with a trend between iPTH and FFST, results from the current study 
mirror those in adults showing an independent association between iPTH concentrations and 
skeletal muscle mass(51). However unlike adults(52), iPTH concentrations in the current 
study were not associated with handgrip strength. Furthermore, based upon adult data alone, 
the positive relationship between iPTH concentrations and IMAT would suggest poor muscle 
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strength(53) as well as an increased risk of diabetes in this early adolescent population(54). To 
our knowledge, there are no studies that have addressed the effect of IMAT on muscle 
strength in a non-diabetic adolescent population, and whether it elicits a negative effect or is 
simply a part of the normal growth process. Similarly, it is important to note that a transient 
diabetic-like state of insulin resistance occurs during early adolescence(55). Whether or not 
this diabetic-like state and potentially a iPTH-induced increase in IMAT are related is 
unclear. Therefore, more research is needed to clarify the role of iPTH and IMAT in early 
adolescent muscle and their potential interaction during the transient diabetic-like state.
Limitations of the present study include: 1) the exclusion of select muscle data due to 
motion artifacts in pQCT-derived images (forearm, n = 34; calf, n = 16), 2) the length of the 
study intervention, 3) participant’s sufficient baseline vitamin D status, and the 4) lack of 
data on prior dietary supplement usage. Though there were significant changes in vitamin D 
metabolites and muscle-related outcomes following the 12-week intervention, based upon 
previous data in adolescents(14,15) a longer study intervention may have generated larger 
changes in outcome variables. Additionally, though a unique aspect of the current study, 
conducting the 12-week intervention in a vitamin D deficient or insufficient population may 
have yielded a greater association between 25(OH)D and muscle-related outcomes, similar 
to previous data in adolescents(14,15) and adults(32-34,38,42,43). Finally, though all participants 
consuming dietary supplements prior to randomization completed a 4-week washout period 
and baseline dietary intakes were not associated with baseline or 12-week changes in any 
study outcome, future researchers should collect data on prior dietary supplement usage as a 
potential covariate in final analyses. The primary strength of this study is that it was a multi-
site vitamin D intervention trial that assessed changes in muscle-related outcomes in both 
black and white and male and female vitamin D sufficient adolescents in the early stages of 
puberty. To our knowledge, this study was also the first to measure IMAT using pQCT in a 
pediatric population. Though a novel approach in pediatric populations, the assessment of 
IMAT using pQCT has previously been documented in adult populations (54,56) and in the 
present study changes in IMAT concentrations were inversely correlated with changes in 
MD and positively correlated with changes in MCSA.
In summary, increases in 25(OH)D were correlated with decreases in forearm IMAT, 
whereas iPTH was positively associated and predicted changes in forearm and calf MCSA 
and IMAT in this diverse early adolescent population. Additional research is needed to 
clarify the relationship between 25(OH)D and IMAT accumulation, the influence of iPTH on 
muscle in early adolescence, and whether these are meaningful relationships.
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Abbreviations:
25(OH)D 25-hydroxyvitamin D
1,25(OH)2D 1,25-dihydroxyvitamin D
RIA Radioimmunoassay
iPTH Intact Parathyroid Hormone
IRMA Immunoradiometric Assay
DXA Dual-energy X-ray Absorptiometry
pQCT Peripheral Quantitative Computed Tomography
FFST Fat-Free Soft Tissue
MCSA Muscle Cross-Sectional Area
MD Muscle Density
IMAT Intermuscular Adipose Tissue
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